4.6 Article

A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans

Journal

GENETICS IN MEDICINE
Volume 20, Issue 9, Pages 1004-1012

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2017.227

Keywords

arylsulfatase G; lysosomal storage disease; retinitis pigmentosa; Usher syndrome; whole-exome sequencing

Funding

  1. Foundation Fighting Blindness USA [BR-GE-0214-0639]
  2. Israel Science Foundation [2154/15]
  3. Chief Scientist Office of the Israeli Ministry of Health
  4. Lirot association [300009177, 300011893]
  5. Yedidut Research Grant
  6. Deutsche Forschungsgemeinschaft [DI 575/101]
  7. Swiss National Science Foundation [156260]

Ask authors/readers for more resources

Purpose: We aimed to identify the cause of disease in patients suffering from a distinctive, atypical form of Usher syndrome. Methods: Whole-exome and genome sequencing were performed in five patients from three families of Yemenite Jewish origin, suffering from distinctive retinal degeneration phenotype and sensorineural hearing loss. Functional analysis of the wild-type and mutant proteins was performed in human fibrosarcoma cells. Results: We identified a homozygous founder missense variant, c. 133G> T (p. D45Y) in arylsulfatase G (ARSG). All patients shared a distinctive retinal phenotype with ring-shaped atrophy along the arcades engirdling the fovea, resulting in ring scotoma. In addition, patients developed moderate to severe sensorineural hearing loss. Both vision and hearing loss appeared around the age of 40 years. The identified variant affected a fully conserved amino acid that is part of the catalytic site of the enzyme. Functional analysis of the wild-type and mutant proteins showed no basal activity of p.D45Y. Conclusion: Homozygosity for ARSG-p.D45Y in humans leads to protein dysfunction, causing an atypical combination of late-onset Usher syndrome. Although there is no evidence for generalized clinical manifestations of lysosomal storage diseases in this set of patients, we cannot rule out the possibility that mild and late-onset symptoms may appear.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available